Syntax Bio, a synthetic biology company programming the next generation of cell therapies, today announced an expanded Series A and new appointments to its executive leadership team, board of ...
CHICAGO--(BUSINESS WIRE)--Syntax Bio, a synthetic biology company programming next generation cell therapies, today announced a research and development collaboration with Mayo Clinic focused on ...
Syntax, a leading global technology solutions provider driving enterprise transformation in the cloud, today announced it has received a Golden Certificate from SAP® in recognition of 10 consecutive ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Ajinomoto Health & Nutrition North America, Inc. (AHN), a leader in amino acid science and cell culture ...
NEW YORK--(BUSINESS WIRE)--Syntax (www.syntaxindices.com), a provider of innovative financial data and technologies, announced that Patrick Shaddow has assumed the role of CEO, effective January 1, ...
If there’s one thing you can be sure of, it’s that English Syntax can definitely get interesting. Syntax is the branch of linguistics that deals with sentences and their structures. In case you’re ...
Syntax Bio, a synthetic biology company programming the next generation of cell therapies, and Applied StemCell Corp. (ASC), a leader in induced pluripotent stem cell (iPSC) technology and genome ...
Syntax Systems, a global technology solutions and services provider for cloud application implementation and management, has officially acquired Montreal-based Beyond Technologies, enabling the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results